277 related articles for article (PubMed ID: 31954196)
21. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD).
Shen Z; Hu B; Tao L; Ma J; Peng R; Zhao Y; Hong J
Front Med (Lausanne); 2023; 10():1277194. PubMed ID: 37964878
[TBL] [Abstract][Full Text] [Related]
23. Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
Ma J; Shen Z; Peng R; Li C; Hu B; Hong J
Transplant Cell Ther; 2021 Mar; 27(3):232.e1-232.e6. PubMed ID: 33781517
[TBL] [Abstract][Full Text] [Related]
24. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
[TBL] [Abstract][Full Text] [Related]
25. In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease.
Kheirkhah A; Qazi Y; Arnoldner MA; Suri K; Dana R
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4686-91. PubMed ID: 27607414
[TBL] [Abstract][Full Text] [Related]
26. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
[TBL] [Abstract][Full Text] [Related]
28. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
29. Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.
Ma J; Li C; Zhao Y; Shen Z; Hu B; Peng R; Hong J
BMC Ophthalmol; 2022 Jan; 22(1):18. PubMed ID: 35012541
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Corneal Epithelial Changes and Related Factors in Ocular Chronic Graft-Versus-Host Disease (GVHD) by in Vivo Confocal Microscopy.
Liu S; Peng R; Ma J; Shen Z; Hu B; Zhao Y; Hong J
Ocul Immunol Inflamm; 2024 May; 32(4):454-462. PubMed ID: 36758227
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease.
Hwang HS; Ha M; Kim HS; Na KS
Ocul Surf; 2019 Jul; 17(3):464-469. PubMed ID: 31015040
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of ocular allergy and dry eye disease.
Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S
Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509
[TBL] [Abstract][Full Text] [Related]
33. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
[TBL] [Abstract][Full Text] [Related]
34. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Messmer EM; von Lindenfels V; Garbe A; Kampik A
Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
[TBL] [Abstract][Full Text] [Related]
35. The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation.
Chen Y; Zhuang X; Wang L; Xu Y; Sun Z; Ren Y; Chen F; Ma X; Tang X; Zhang X
Ocul Immunol Inflamm; 2024 Jan; ():1-8. PubMed ID: 38252122
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of the IL-33/ST2 pathway in dry eye.
Wang S; Zhang H
Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.
Cocho L; Fernández I; Calonge M; Martínez V; González-García MJ; Caballero D; López-Corral L; García-Vázquez C; Vázquez L; Stern ME; Enríquez-de-Salamanca A
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):746-58. PubMed ID: 26927568
[TBL] [Abstract][Full Text] [Related]
38. Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.
Amparo F; Shikari H; Saboo U; Dana R
Ocul Surf; 2018 Jul; 16(3):377-381. PubMed ID: 29763694
[TBL] [Abstract][Full Text] [Related]
39. Tear biomarkers in dry eye disease: Progress in the last decade.
Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
[TBL] [Abstract][Full Text] [Related]
40. Effect of maqui-berry extract in dry eye disease - A clinical and molecular analysis.
Kundu G; Shetty R; D'Souza S; Gorimanipalli B; Koul A; Sethu S
Indian J Ophthalmol; 2023 Apr; 71(4):1613-1618. PubMed ID: 37026311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
